Summary
MetLife, Inc. (MET) filed a Form 8-K on May 2, 2014, to correct a misstatement made during their first quarter 2014 earnings call on May 1, 2014. The company inadvertently provided an incorrect figure regarding the year-over-year increase in cancer sales in Japan. Specifically, MetLife corrected the reported increase in cancer sales in Japan from approximately 120% to approximately 20%. This filing is primarily a clarification of previously released information and does not introduce new financial results or significant operational updates beyond this specific correction. Investors should note this correction to ensure they have the most accurate data available regarding MetLife's performance in the Japanese market during that period.
Key Highlights
- 1Correction of a financial misstatement related to first quarter 2014 earnings.
- 2The misstatement concerned the year-over-year increase in cancer sales in Japan.
- 3Corrected cancer sales increase in Japan from approximately 120% to approximately 20%.
- 4The information was provided during the Q1 2014 earnings call.
- 5The filing was made on May 2, 2014, to address the error.
- 6This filing is furnished and not filed pursuant to Instruction B.2 of Form 8-K, meaning it's for informational purposes and not subject to specific SEC review for this item.